Jilin Institute of Traditional Chinese Medicine

Using placebo as the control and the change in total exercise time of the exercise test as the main efficacy indicator, the clinical efficacy and safety of FJZHT03 in the treatment of angina pectoris (chest pain, qi deficiency and blood stasis syndrome) of coronary heart disease were evaluated to confirm its market value.

To explore the efficacy and safety of Shushe Weikexin capsules alone or in combination with ranitidine hydrochloride capsules in the treatment of duodenal ulcer with liver-stomach heat syndrome.

To evaluate the safety and efficacy of Sanyang Yixinkang capsule in the treatment of angina pectoris (yang deficiency and blood stasis syndrome) in coronary heart disease